業界のプレスリリース
24 Mar 2021

GEA presents the single-use disc stack separator kytero® for cell harvesting at the virtual fair ACHEMA Pulse. (Photo: GEA)
Preceded by a rigorous development and testing process, the result combines the outstanding performance of larger GEA stainless steel pharma centrifuges with the features and benefits that single-use separation provides. This type of equipment is in high demand among biopharmaceutical manufacturers worldwide.
The new single-use GEA kytero® separator is designed for harvesting fermentation broths and cell cultures and comes equipped with proven GEA Westfalia separator disc stack technology for maximum yield, high separation efficiency and gentle product handling.
GEA kytero® integrates a world-new low noise centrifuge technology – the GEA breezedrive®. The robust and reliable single-use separator reduces the amount of production space required thanks to its small footprint. Likewise, it can be used without buffer addition and substantially reduces filtration requirements.
Every aspect of the GEA kytero® is user-friendly and easy to handle. Any product contact part, such as cartridges or pathways, are replaced after each use. This prevents cross-contamination and guarantees contained cell harvesting. The design of the aseptic connector system means exchanging single-use components is quick and very easy to do.
The small footprint of the single-use GEA separator kytero® makes it highly mobile and minimizes the need for expensive storage or production space. By eliminating the need for CIP and SIP, costs for chemicals and water, as well as a water for injection (WFI) system, are also negated. Additionally, the energy and effort required for cleaning and sterilizing is reduced.
GEA kytero® will become available as of September 2021. Audience at ACHEMA Pulse are invited to find out more about the single-use GEA kytero® separator.
Dr. Michael Golek
Media Relations
GEA Group Aktiengesellschaft
Ulmenstrasse 99
40476
Düsseldorf
Germany
+49 211 9136-0
GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries.
The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. For instance, every second pharma separator for essential healthcare products such as vaccines or novel biopharmaceuticals is produced by GEA. In food, every fourth package of pasta or every third chicken nugget are processed with GEA technology.
With more than 18,000 employees, the group generated sales of about EUR 5.5 billion in more than 150 countries in the 2025 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customers’ production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world.”
GEA is listed on the German MDAX, the European STOXX® Europe 600 Index and is also a constituent of the leading sustainability indices DAX 50 ESG, MSCI Global Sustainability and Dow Jones Best-in-Class World.